Citations (189)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Caiqin Yan, Ting Peng, Tingting Zhang, Yuan Wang, Na Li, Kai Wang & Xijuan Jiang. (2023) Molecular mechanisms of hepatotoxicity induced by compounds occurring in Evodiae Fructus. Drug Metabolism Reviews 55:1-2, pages 75-93.
Read now
Read now
Linlin Hu, Fei Wu, Jie He, Lingjun Zhong, Yifan Song & Hua Shao. (2019) Cytotoxicity of safrole in HepaRG cells: studies on the role of CYP1A2-mediated ortho-quinone metabolic activation. Xenobiotica 49:12, pages 1504-1515.
Read now
Read now
Agnieszka Potęga, Dorota Garwolińska, Anna M. Nowicka, Michał Fau, Agata Kot-Wasik & Zofia Mazerska. (2019) Phase I and phase II metabolism simulation of antitumor-active 2-hydroxyacridinone with electrochemistry coupled on-line with mass spectrometry. Xenobiotica 49:8, pages 922-934.
Read now
Read now
Xin-Yu Zhang & Adnan A. Elfarra. (2017) Potential roles of myeloperoxidase and hypochlorous acid in metabolism and toxicity of alkene hydrocarbons and drug molecules containing olefinic moieties. Expert Opinion on Drug Metabolism & Toxicology 13:5, pages 513-524.
Read now
Read now
Sun-Jae Lee, Youn Ju Lee & Kwan-Kyu Park. (2016) The pathogenesis of drug-induced liver injury. Expert Review of Gastroenterology & Hepatology 10:10, pages 1175-1185.
Read now
Read now
Mark P Grillo. (2015) Detecting reactive drug metabolites for reducing the potential for drug toxicity. Expert Opinion on Drug Metabolism & Toxicology 11:8, pages 1281-1302.
Read now
Read now
Deepak Dalvie, Amit S. Kalgutkar & Weichao Chen. (2015) Practical approaches to resolving reactive metabolite liabilities in early discovery. Drug Metabolism Reviews 47:1, pages 56-70.
Read now
Read now
. (2014) ABSTRACTS FROM THE 10TH INTERNATIONAL ISSX MEETING. Drug Metabolism Reviews 45:sup1, pages 1-286.
Read now
Read now
Yin Cheong Wong, Shuai Qian & Zhong Zuo. (2012) Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions. Expert Opinion on Drug Metabolism & Toxicology 8:7, pages 833-854.
Read now
Read now
Louis Leung, Amit S. Kalgutkar & R. Scott Obach. (2012) Metabolic activation in drug-induced liver injury. Drug Metabolism Reviews 44:1, pages 18-33.
Read now
Read now
Claire M Ellison, Steven J Enoch & Mark TD Cronin. (2011) A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity. Expert Opinion on Drug Metabolism & Toxicology 7:12, pages 1481-1495.
Read now
Read now
S. J. Enoch & M. T. D. Cronin. (2010) A review of the electrophilic reaction chemistry involved in covalent DNA binding. Critical Reviews in Toxicology 40:8, pages 728-748.
Read now
Read now
Wei Tang & Anthony Y.H. Lu. (2010) Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective. Drug Metabolism Reviews 42:2, pages 225-249.
Read now
Read now
K.S. Frederick, T.S. Maurer, A.S. Kalgutkar, L.J. Royer, O.L. Francone, S.M. Winter, S.G. Terra, D. Chen & X. Gao. (2009) Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor α agonist in preclinical species and human. Xenobiotica 39:10, pages 766-781.
Read now
Read now
Bo Wen & William L Fitch. (2009) Analytical strategies for the screening and evaluation of chemically reactive drug metabolites. Expert Opinion on Drug Metabolism & Toxicology 5:1, pages 39-55.
Read now
Read now
Amit S Kalgutkar, Gwendolyn Fate, Mary T Didiuk & Jonathan Bauman. (2008) Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?. Expert Review of Clinical Pharmacology 1:4, pages 515-531.
Read now
Read now
J. C. L. Erve, S. C. Vashishtha, O. Ojewoye, A. Adedoyin, R. Espina, W. DeMaio & R. E. Talaat. (2008) Metabolism of prazosin in rat and characterization of metabolites in plasma, urine, faeces, brain and bile using liquid chromatography/mass spectrometry (LC/MS). Xenobiotica 38:5, pages 540-558.
Read now
Read now
William W. Johnson. (2008) Cytochrome P450 Inactivation by Pharmaceuticals and Phytochemicals: Therapeutic Relevance. Drug Metabolism Reviews 40:1, pages 101-147.
Read now
Read now
Wei Tang. (2007) Drug metabolite profiling and elucidation of drug-induced hepatotoxicity. Expert Opinion on Drug Metabolism & Toxicology 3:3, pages 407-420.
Read now
Read now
Articles from other publishers (170)
Zhiqin Zhu, Zheng Yao, Xin Zheng, Guanqiu Qi, Yuanyuan Li, Neal Mazur, Xinbo Gao, Yifei Gong & Baisen Cong. (2023) Drug–target affinity prediction method based on multi-scale information interaction and graph optimization. Computers in Biology and Medicine 167, pages 107621.
Crossref
Crossref
Michael Murray. (2023) Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents. Clinical Pharmacokinetics 62:10, pages 1365-1392.
Crossref
Crossref
Leslie Salas-Estrada, Davide Provasi, Xing Qiu, Husnu Ümit Kaniskan, Xi-Ping Huang, Jeffrey F. DiBerto, João Marcelo Lamim Ribeiro, Jian Jin, Bryan L. Roth & Marta Filizola. (2023) De Novo Design of κ-Opioid Receptor Antagonists Using a Generative Deep-Learning Framework. Journal of Chemical Information and Modeling 63:16, pages 5056-5065.
Crossref
Crossref
Paul Thomson, Nik Fragkas, Laila M. Kafu, Guruprasad P. Aithal, M. Isabel Lucena, Luigi Terracciano, Xiaoli Meng, Munir Pirmohamed, Dominique Brees, Gerd A. Kullak‐Ublick, Alex Odermatt, Thomas Hammond, Michael Kammüller & Dean J. Naisbitt. (2023)
Patients with
naproxen‐induced
liver injury display T‐cell memory responses toward an oxidative (S)‐
O‐Desmethyl
Naproxen metabolite but not the acyl glucuronide
. Allergy.
Crossref
Crossref
Paul Thomson, Sean Hammond, Xiaoli Meng & Dean J. Naisbitt. (2023) What’s been Hapten-ing over the last 88 years?. Medicinal Chemistry Research.
Crossref
Crossref
Elizabeth A. Jurica, Ximao Wu, Kristin N. Williams, Lauren E. Haque, Richard A. Rampulla, Arvind Mathur, Min Zhou, Gary Cao, Hong Cai, Tao Wang, Heng Liu, Carrie Xu, Lori K. Kunselman, Thomas M. Antrilli, Michael B. Hicks, Qin Sun, Elizabeth A. Dierks, Atsu Apedo, Douglas B. Moore, Kimberly A. Foster, Mary Ellen Cvijic, Reshma Panemangalore, Purnima Khandelwal, Jason J. Wilkes, Bradley A. Zinker, Donald G. Robertson, Evan B. Janovitz, Michael Galella, Yi-Xin Li, Julia Li, Thangeswaran Ramar, Prasada Rao Jalagam, Ramya Jayaram, Jean M. Whaley, Joel C. Barrish, Jeffrey A. Robl, William R. Ewing & Bruce A. Ellsworth. (2023) Optimization of physicochemical properties of pyrrolidine GPR40 AgoPAMs results in a differentiated profile with improved pharmacokinetics and reduced off-target activities. Bioorganic & Medicinal Chemistry 85, pages 117273.
Crossref
Crossref
Ridho Asra & Alan M Jones. (2023) Green electrosynthesis of drug metabolites. Toxicology Research 12:2, pages 150-177.
Crossref
Crossref
Yuan Liu, Menglong Li & Zhining Wen. 2023. QSAR in Safety Evaluation and Risk Assessment. QSAR in Safety Evaluation and Risk Assessment
273
292
.
MARK P. GRILLO. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
703
743
.
DAN A. ROCK & LARRY C. WIENKERS. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
465
526
.
Jiaqi Liao, Haoyang Chen, Lesong Wei & Leyi Wei. (2022) GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information. Computers in Biology and Medicine 150, pages 106145.
Crossref
Crossref
Morgan Thomas, Noel M. O’Boyle, Andreas Bender & Chris de Graaf. (2022) Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation. Journal of Cheminformatics 14:1.
Crossref
Crossref
Zifang Ding, Xu Wang, Ning Zhang, Chen Sun, Guode Zhao, Ying Peng & Jiang Zheng. (2022) Metabolic Activation of Perampanel Mediated by CYP1A2. Chemical Research in Toxicology 35:3, pages 490-498.
Crossref
Crossref
Liyuan Kang, Yifei Duan, Cheng Chen, Shihai Li, Menglong Li, Lei Chen & Zhining Wen. (2022) Structure-Activity Relationship (SAR) Model for Predicting Teratogenic Risk of Antiseizure Medications in Pregnancy by Using Support Vector Machine. Frontiers in Pharmacology 13.
Crossref
Crossref
Ziduo Yang, Weihe Zhong, Lu Zhao & Calvin Yu-Chian Chen. (2022) MGraphDTA: deep multiscale graph neural network for explainable drug–target binding affinity prediction. Chemical Science 13:3, pages 816-833.
Crossref
Crossref
Akhileshwar Kumar Srivastava, Dhruv Kumar, Divya Singh & Rajesh Kumar Singh. 2022. Xenobiotics in Chemical Carcinogenesis. Xenobiotics in Chemical Carcinogenesis
261
282
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
290
297
.
Morgan Thomas, Robert T. Smith, Noel M. O’Boyle, Chris de Graaf & Andreas Bender. (2021) Comparison of structure- and ligand-based scoring functions for deep generative models: a GPCR case study. Journal of Cheminformatics 13:1.
Crossref
Crossref
Jiyuan Ma, Nicole Risher, Valerie Northcutt, Young-Choon Moon, Marla Weetall, Ellen Welch, Joseph Colacino, Neil Almstead & Ronald Kong. (2021) Ataluren metabolism: Ataluren-O-1β-acyl glucuronide is a stable circulating metabolite in mouse, rat, dog and human. Drug Metabolism and Pharmacokinetics 38, pages 100393.
Crossref
Crossref
Matthias R. Bauer, Paolo Di Fruscia, Simon C. C. Lucas, Iacovos N. Michaelides, Jennifer E. Nelson, R. Ian Storer & Benjamin C. Whitehurst. (2021) Put a ring on it: application of small aliphatic rings in medicinal chemistry. RSC Medicinal Chemistry 12:4, pages 448-471.
Crossref
Crossref
Donald J. AbrahamDeepak K. Dalvie & Bernard Testa. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
139
.
Tyler B. Hughes, Noah Flynn, Na Le Dang & S. Joshua Swamidass. (2021) Modeling the Bioactivation and Subsequent Reactivity of Drugs. Chemical Research in Toxicology 34:2, pages 584-600.
Crossref
Crossref
F. Peter Guengerich. (2020) A history of the roles of cytochrome P450 enzymes in the toxicity of drugs. Toxicological Research 37:1, pages 1-23.
Crossref
Crossref
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
8
.
Kevin M. Johnson, Dian Su & Donglu Zhang. 2021. Cytochrome P450. Cytochrome P450
27
54
.
Alberga Domenico, Gambacorta Nicola, Trisciuzzi Daniela, Ciriaco Fulvio, Amoroso Nicola & Nicolotti Orazio. (2020)
De Novo
Drug Design of Targeted Chemical Libraries Based on Artificial Intelligence and Pair-Based Multiobjective Optimization
. Journal of Chemical Information and Modeling 60:10, pages 4582-4593.
Crossref
Crossref
Jie Jack Li. 2020. Medicinal Chemistry for Practitioners. Medicinal Chemistry for Practitioners
305
379
.
Hongbin Yang, Chaofeng Lou, Weihua Li, Guixia Liu & Yun Tang. (2020) Computational Approaches to Identify Structural Alerts and Their Applications in Environmental Toxicology and Drug Discovery. Chemical Research in Toxicology 33:6, pages 1312-1322.
Crossref
Crossref
Zi-Yi Yang, Jun-Hong He, Ai-Ping Lu, Ting-Jun Hou & Dong-Sheng Cao. (2020) Application of Negative Design To Design a More Desirable Virtual Screening Library. Journal of Medicinal Chemistry 63:9, pages 4411-4429.
Crossref
Crossref
Mónica García, Marina Virgili, Mònica Alonso, Carles Alegret, Begoña Fernández, Adriana Port, Rosalía Pascual, Xavier Monroy, Alba Vidal-Torres, María-Teresa Serafini, José Miguel Vela & Carmen Almansa. (2019)
4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ
1
Receptor Antagonists for the Treatment of Pain
. Journal of Medicinal Chemistry 63:5, pages 2434-2454.
Crossref
Crossref
Jaydeep Yadav, Erickson Paragas, Ken Korzekwa & Swati Nagar. (2020) Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions. Pharmacology & Therapeutics 206, pages 107449.
Crossref
Crossref
Devin Hunt, Megan Branson, Elizabeth Putnam & Mark Pershouse. 2020. Information Resources in Toxicology. Information Resources in Toxicology
415
423
.
Lu-Lin CHEN, Can-Hui CHEN, Xing-Xian ZHANG, Yi WANG & Shu-Fang WANG. (2019) Identification of constituents in Gui-Zhi-Jia-Ge-Gen-Tang by LC-IT-MS combined with LC-Q-TOF-MS and elucidation of their metabolic networks in rat plasma after oral administration. Chinese Journal of Natural Medicines 17:11, pages 803-821.
Crossref
Crossref
Yuyang Liu, Ying Peng, Zhengyu Zhang, Xiucai Guo, Mingshan Ji & Jiang Zheng. (2019) In vitro and in vivo studies of the metabolic activation of chelidonine. Chemico-Biological Interactions 308, pages 155-163.
Crossref
Crossref
Yuanfu Lu, Xue-Mei Zhao, Zhaoyong Hu, Li Wang & Feng Li. (2018) LC–MS-Based Metabolomics in the Study of Drug-Induced Liver Injury. Current Pharmacology Reports 5:1, pages 56-67.
Crossref
Crossref
Nobuyuki Kakutani, Toyomichi Nanayama & Yukihiro Nomura. (2019) Novel risk assessment of reactive metabolites from discovery to clinical stage. The Journal of Toxicological Sciences 44:3, pages 201-211.
Crossref
Crossref
Ruijuan Liu, Fang Zhou, He He, Jingyao Wei, Xin Tian & Li Ding. (2018) Metabolism and Bioactivation of Corynoline With Characterization of the Glutathione/Cysteine Conjugate and Evaluation of Its Hepatotoxicity in Mice. Frontiers in Pharmacology 9.
Crossref
Crossref
Kamil Piska, Agnieszka Galanty, Paulina Koczurkiewicz, Paweł Żmudzki, Joanna Potaczek, Irma Podolak & Elżbieta Pękala. (2018) Usnic acid reactive metabolites formation in human, rat, and mice microsomes. Implication for hepatotoxicity. Food and Chemical Toxicology 120, pages 112-118.
Crossref
Crossref
D. Bosc, L. Vezenkov, S. Bortnik, J. An, J. Xu, C. Choutka, A. M. Hannigan, S. Kovacic, S. Loo, P. G. K. Clark, G. Chen, R. N. Guay-Ross, K. Yang, W. H. Dragowska, F. Zhang, N. E. Go, A. Leung, N. S. Honson, T. A. Pfeifer, M. Gleave, M. Bally, S. J. Jones, S. M. Gorski & R. N. Young. (2018) A new quinoline-based chemical probe inhibits the autophagy-related cysteine protease ATG4B. Scientific Reports 8:1.
Crossref
Crossref
Alf Claesson & Alexander Minidis. (2018) Systematic Approach to Organizing Structural Alerts for Reactive Metabolite Formation from Potential Drugs. Chemical Research in Toxicology 31:6, pages 389-411.
Crossref
Crossref
Carmen Limban, Diana C. Nuţă, Cornel Chiriţă, Simona Negreș, Andreea L. Arsene, Marina Goumenou, Spyros P. Karakitsios, Aristidis M. Tsatsakis & Dimosthenis A. Sarigiannis. (2018) The use of structural alerts to avoid the toxicity of pharmaceuticals. Toxicology Reports 5, pages 943-953.
Crossref
Crossref
Tomoko Ogiyama, Mitsuhiro Yamaguchi, Nobuya Kurikawa, Shoko Honzumi, Koji Terayama, Nobumi Nagaoka, Yuka Yamamoto, Takako Kimura, Daisuke Sugiyama & Shin-ichi Inoue. (2017) Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor. Bioorganic & Medicinal Chemistry 25:17, pages 4817-4828.
Crossref
Crossref
Daniel S. La, Emily A. Peterson, Christiane Bode, Alessandro A. Boezio, Howard Bregman, Margaret Y. Chu-Moyer, James Coats, Erin F. DiMauro, Thomas A. Dineen, Bingfan Du, Hua Gao, Russell Graceffa, Hakan Gunaydin, Angel Guzman-Perez, Robert FremeauJr.Jr., Xin Huang, Christopher Ilch, Thomas J. Kornecook, Charles Kreiman, Joseph Ligutti, Min-Hwa Jasmine Lin, Jeff S. McDermott, Isaac Marx, David J. Matson, Stefan I. McDonough, Bryan D. Moyer, Hanh Nho Nguyen, Kristin Taborn, Violeta Yu & Matthew M. Weiss. (2017) The discovery of benzoxazine sulfonamide inhibitors of Na V 1.7: Tools that bridge efficacy and target engagement. Bioorganic & Medicinal Chemistry Letters 27:15, pages 3477-3485.
Crossref
Crossref
Matthew M. Weiss, Thomas A. Dineen, Isaac E. Marx, Steven Altmann, Alessandro Boezio, Howard Bregman, Margaret Chu-Moyer, Erin F. DiMauro, Elma Feric Bojic, Robert S. Foti, Hua Gao, Russell Graceffa, Hakan Gunaydin, Angel Guzman-Perez, Hongbing Huang, Liyue Huang, Michael Jarosh, Thomas Kornecook, Charles R. Kreiman, Joseph Ligutti, Daniel S. La, Min-Hwa Jasmine Lin, Dong Liu, Bryan D. Moyer, Hanh N. Nguyen, Emily A. Peterson, Paul E. Rose, Kristin Taborn, Beth D. Youngblood, Violeta Yu & Robert T. FremeauJr.Jr.. (2017)
Sulfonamides as Selective Na
V
1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
. Journal of Medicinal Chemistry 60:14, pages 5969-5989.
Crossref
Crossref
Michiel W. den Braver, Nico P.E. Vermeulen & Jan N.M. Commandeur. (2017) Generic method for the absolute quantification of glutathione S-conjugates: Application to the conjugates of acetaminophen, clozapine and diclofenac. Journal of Chromatography B 1046, pages 185-194.
Crossref
Crossref
Julie A. Spicer, Christian K. Miller, Patrick D. O'Connor, Jiney Jose, Kristiina M. Huttunen, Jagdish K. Jaiswal, William A. Denny, Hedieh Akhlaghi, Kylie A. Browne & Joseph A. Trapani. (2017) Benzenesulphonamide inhibitors of the cytolytic protein perforin. Bioorganic & Medicinal Chemistry Letters 27:4, pages 1050-1054.
Crossref
Crossref
Susumu Yamanobe, Hiroshi Kawamoto & Norikazu Ohtake. (2017) Design of high-quality compound library and open innovation. Folia Pharmacologica Japonica 149:4, pages 180-185.
Crossref
Crossref
Pinning Feng, Xinrong Hu, Xiaoliang Wu, Jun Dong & Xiuyu Cai. (2016) Characterization of an epoxide-derived metabolite of dictamnine using high-performance liquid chromatography with hybrid linear trap quadrupole orbitrap mass spectrometry. Journal of Separation Science 39:24, pages 4858-4865.
Crossref
Crossref
M. José Gómez-Lechón, Laia Tolosa & M. Teresa Donato. (2016)
Metabolic activation and drug-induced liver injury:
in vitro
approaches for the safety risk assessment of new drugs
. Journal of Applied Toxicology 36:6, pages 752-768.
Crossref
Crossref
Richard A. Thompson, Emre M. Isin, Monday O. Ogese, Jerome T. Mettetal & Dominic P. Williams. (2016) Reactive Metabolites: Current and Emerging Risk and Hazard Assessments. Chemical Research in Toxicology 29:4, pages 505-533.
Crossref
Crossref
James A. Akingbasote, Alison J. Foster, Ian Wilson, Sunil Sarda, Huw B. Jones & J. Gerry Kenna. (2015) Hepatic effects of repeated oral administration of diclofenac to hepatic cytochrome P450 reductase null (HRN™) and wild-type mice. Archives of Toxicology 90:4, pages 853-862.
Crossref
Crossref
Andreas Svennebring. (2016) The role of intramolecular self-destruction of reactive metabolic intermediates in determining toxicity. Journal of Applied Toxicology 36:4, pages 483-500.
Crossref
Crossref
Meina Chi, Ying Peng & Jiang Zheng. (2016) Characterization of glutathione conjugates derived from reactive metabolites of bakuchiol. Chemico-Biological Interactions 244, pages 178-186.
Crossref
Crossref
J. Richard Morphy. 2015. Attrition in the Pharmaceutical Industry. Attrition in the Pharmaceutical Industry
215
228
.
Xu Mao, Ying Peng & Jiang Zheng. (2015) In Vitro and In Vivo Characterization of Reactive Intermediates of Corynoline. Drug Metabolism and Disposition 43:10, pages 1491-1498.
Crossref
Crossref
Axel Rydevik, Annelie Hansson, Anna Hellqvist, Ulf Bondesson & Mikael Hedeland. (2015)
A novel trapping system for the detection of reactive drug metabolites using the fungus
Cunninghamella elegans
and high resolution mass spectrometry
. Drug Testing and Analysis 7:7, pages 626-633.
Crossref
Crossref
Ke Huang, Lingyi Huang & Richard B. van Breemen. (2015) Detection of Reactive Metabolites Using Isotope-Labeled Glutathione Trapping and Simultaneous Neutral Loss and Precursor Ion Scanning with Ultra-High-Pressure Liquid Chromatography Triple Quadruple Mass Spectrometry. Analytical Chemistry 87:7, pages 3646-3654.
Crossref
Crossref
Bertrand Rochat, Elyes Dahmane, Kalil Zaman & Chantal Csajka. (2015) Improved Investigations in Drug Safety by More In-Depth Individual Pharmacokinetics Using High-Resolution Mass Spectrometry. Therapeutic Drug Monitoring 37:2, pages 141-146.
Crossref
Crossref
Peter Imming. 2015. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry
3
13
.
Abhishek Srivastava, Sreekanth Ramachandran, Shahul P. Hameed, VijayKamal Ahuja & Vinayak P. Hosagrahara. (2014) Identification and Mitigation of a Reactive Metabolite Liability Associated with Aminoimidazoles. Chemical Research in Toxicology 27:9, pages 1586-1597.
Crossref
Crossref
Shyam Sundhar Bale, Lawrence Vernetti, Nina Senutovitch, Rohit Jindal, Manjunath Hegde, Albert Gough, William J McCarty, Ahmet Bakan, Abhinav Bhushan, Tong Y Shun, Inna Golberg, Richard DeBiasio, O Berk Usta, D Lansing Taylor & Martin L Yarmush. (2014)
In vitro
platforms for evaluating liver toxicity
. Experimental Biology and Medicine 239:9, pages 1180-1191.
Crossref
Crossref
Varun Ahuja & Sharad Sharma. (2014) Drug safety testing paradigm, current progress and future challenges: an overview. Journal of Applied Toxicology 34:6, pages 576-594.
Crossref
Crossref
Vincent Mascitti & Ralph P. Robinson. 2014. Natural Products in Medicinal Chemistry. Natural Products in Medicinal Chemistry
301
332
.
Malinee Promkatkaew, Duangkamol Gleeson, Supa Hannongbua & M. Paul Gleeson. (2014)
Skin Sensitization Prediction Using Quantum Chemical Calculations: A Theoretical Model for the S
N
Ar Domain
. Chemical Research in Toxicology 27:1, pages 51-60.
Crossref
Crossref
Antonia F. Stepan & Amit S. Kalgutkar. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
33
.
Chenghong Zhang, Shuguang Ma, Erlie Marie Delarosa, Suzanne Tay, Jasleen Sodhi, Vivek Musinipally, Patricia Chang, Rama Pai, Jason S. Halladay, Dinah Misner, Jane R. Kenny, Cornelis E. C. A. Hop & S. Cyrus Khojasteh. (2014) For a series of methylindole analogs, reactive metabolite formation is a poor predictor of intrinsic cytotoxicity in human hepatocytes. Toxicology Research 3:3, pages 184.
Crossref
Crossref
Tonika Bohnert & Lawrence L. Gan. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
61
.
Andrew V. Stachulski, Thomas A. Baillie, B. Kevin Park, R. Scott Obach, Deepak K. Dalvie, Dominic P. Williams, Abhishek Srivastava, Sophie L. Regan, Daniel J. Antoine, Christopher E. P. Goldring, Alvin J. L. Chia, Neil R. Kitteringham, Laura E. Randle, Hayley Callan, J. Luis Castrejon, John Farrell, Dean J. Naisbitt & Martin S. Lennard. (2013) The Generation, Detection, and Effects of Reactive Drug Metabolites. Medicinal Research Reviews 33:5, pages 985-1080.
Crossref
Crossref
Li-Fang Yu, Yuan-Yuan Li, Ming-Bo Su, Mei Zhang, Wei Zhang, Li-Na Zhang, Tao Pang, Run-Tao Zhang, Bing Liu, Jing-Ya Li, Jia Li & Fa-Jun Nan. (2013) Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators. ACS Medicinal Chemistry Letters 4:5, pages 475-480.
Crossref
Crossref
Minli Zhang, Christina M. Resuello, Jian Guo, Mark E. Powell, Charles S. Elmore, Jun Hu & Karthick Vishwanathan. (2013)
Contribution of Artifacts to
N
-Methylated Piperazine Cyanide Adduct Formation In Vitro from
N
-Alkyl Piperazine Analogs
. Drug Metabolism and Disposition 41:5, pages 1023-1034.
Crossref
Crossref
Austin C. Li, Erya Yu, Steven C. Ring & James P. Chovan. (2013) Boronic Acid-Containing Proteasome Inhibitors: Alert to Potential Pharmaceutical Bioactivation. Chemical Research in Toxicology 26:4, pages 608-615.
Crossref
Crossref
Richard Kia, Rowena L. C. Sison, James Heslop, Neil R. Kitteringham, Neil Hanley, John S. Mills, B. Kevin Park & Chris E. P. Goldring. (2013) Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?. British Journal of Clinical Pharmacology 75:4, pages 885-896.
Crossref
Crossref
Shuguang Ma & Swapan K. Chowdhury. 2013. Mass Spectrometry for Drug Discovery and Drug Development. Mass Spectrometry for Drug Discovery and Drug Development
339
355
.
Vincent Mascitti, Benjamin A. Thuma, Aaron C. Smith, Ralph P. Robinson, Thomas Brandt, Amit S. Kalgutkar, Tristan S. Maurer, Brian Samas & Raman Sharma. (2013) On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin. MedChemComm 4:1, pages 101-111.
Crossref
Crossref
Kentaro Futatsugi, Vincent Mascitti, Cristiano R.W. Guimarães, Nao Morishita, Cuiman Cai, Michael P. DeNinno, Hua Gao, Michael D. Hamilton, Richard Hank, Anthony R. Harris, Daniel W. Kung, Sophie Y. Lavergne, Bruce A. Lefker, Michael G. Lopaze, Kim F. McClure, Michael J. Munchhof, Cathy Preville, Ralph P. Robinson, Stephen W. Wright, Paul D. Bonin, Peter Cornelius, Yue Chen & Amit S. Kalgutkar. (2013) From partial to full agonism: Identification of a novel 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole as a full agonist of the human GPR119 receptor. Bioorganic & Medicinal Chemistry Letters 23:1, pages 194-197.
Crossref
Crossref
Douglas K. Spracklin, Amit S. Kalgutkar & Angus N. R. Nedderman. 2014. Reducing Drug Attrition. Reducing Drug Attrition
97
137
.
Yalda Soltanpour, Constanze Hilgendorf, Marie M. Ahlström, Alison J. Foster, J. Gerry Kenna, Anne Petersen & Anna-Lena Ungell. (2012) Characterization of THLE-Cytochrome P450 (P450) Cell Lines: Gene Expression Background and Relationship to P450-Enzyme Activity. Drug Metabolism and Disposition 40:11, pages 2054-2058.
Crossref
Crossref
Zhong‐Ze Fang, Kristopher W Krausz, Fei Li, Jie Cheng, Naoki Tanaka & Frank J Gonzalez. (2012) Metabolic map and bioactivation of the anti‐tumour drug noscapine. British Journal of Pharmacology 167:6, pages 1271-1286.
Crossref
Crossref
Amit S. Kalgutkar, Deepak Dalvie, R. Scott Obach & Dennis A. Smith. 2012. Reactive Drug Metabolites. Reactive Drug Metabolites
93
129
.
Amit S. Kalgutkar, Deepak Dalvie, R. Scott Obach & Dennis A. Smith. 2012. Reactive Drug Metabolites. Reactive Drug Metabolites
225
240
.
Alexander V. LyubimovDavid C. Evans. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
45
.
Iurii Sushko, Elena Salmina, Vladimir A. Potemkin, Gennadiy Poda & Igor V. Tetko. (2012) ToxAlerts: A Web Server of Structural Alerts for Toxic Chemicals and Compounds with Potential Adverse Reactions. Journal of Chemical Information and Modeling 52:8, pages 2310-2316.
Crossref
Crossref
Jean-Pierre Maffrand. (2012) The story of clopidogrel and its predecessor, ticlopidine: Could these major antiplatelet and antithrombotic drugs be discovered and developed today?. Comptes Rendus Chimie 15:8, pages 737-743.
Crossref
Crossref
Cristina Losada, Joan J. Albertí, Javier Saurina & Sonia Sentellas. (2012) Determination of S-containing drug metabolites from in vitro and in vivo metabolism studies by using LC-ICP/MS. Analytical and Bioanalytical Chemistry 404:2, pages 539-551.
Crossref
Crossref
David J. St. JeanJr.Jr. & Christopher Fotsch. (2012) Mitigating Heterocycle Metabolism in Drug Discovery. Journal of Medicinal Chemistry 55:13, pages 6002-6020.
Crossref
Crossref
Alexander V. LyubimovAmit S. Kalgutkar & Jonathan N. Bauman. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
26
.
Alexander V. LyubimovHayley M. Webb, Sophie Regan, Daniel J. Antoine, Nicola Lane, Rachel J. Walsh, Abhishek Srivastava, Philip Starkey‐Lewis, Craig Benson, Dominic P. Williams, Hugh Laverty, Christopher Goldring & B. Kevin Park. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
44
.
Chin Yee Liew, Chuen Pan, Andre Tan, Ke Xin Magneline Ang & Chun Wei Yap. (2012) QSAR classification of metabolic activation of chemicals into covalently reactive species. Molecular Diversity 16:2, pages 389-400.
Crossref
Crossref
Robert J. Weikert. 2012. Designing Multi-Target Drugs. Designing Multi-Target Drugs
270
289
.
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
159
208
.
Zhi-peng Deng, Da-fang Zhong, Jian Meng & Xiao-yan Chen. (2012) Covalent protein binding and tissue distribution of houttuynin in rats after intravenous administration of sodium houttuyfonate. Acta Pharmacologica Sinica 33:4, pages 568-576.
Crossref
Crossref
Shengkai Liao, Nigel P. Ewing, Brian Boucher, Olivier Materne & Christopher L. Brummel. (2012) High-throughput screening for glutathione conjugates using stable-isotope labeling and negative electrospray ionization precursor-ion mass spectrometry. Rapid Communications in Mass Spectrometry 26:6, pages 659-669.
Crossref
Crossref
D.P. Williams, Amy Lawrence & Xiaoli Meng. (2012) Pharmacological and Toxicological Considerations of Homogentisic Acid in Alkaptonuria. Pharmacologia 3:3, pages 61-74.
Crossref
Crossref
Alexander V. LyubimovDeepak K. Dalvie. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
54
.
Alexander V. LyubimovThomas A. Baillie. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
24
.
Alexander V. LyubimovMatthew J. Hutzler & Matthew A. Cerny. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
40
.
D. J. Snodin & A. Suitters. 2011. Stephens' Detection and Evaluation of Adverse Drug Reactions. Stephens' Detection and Evaluation of Adverse Drug Reactions
157
214
.
Suzanne Geenen, Cristina Guallar-Hoyas, Filippos Michopoulos, J. Gerry Kenna, Kyle L. Kolaja, Hans. V. Westerhoff, Paul Thomas & Ian D. Wilson. (2011) HPLC–MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium. Journal of Pharmaceutical and Biomedical Analysis 56:3, pages 655-663.
Crossref
Crossref
Moa Andresen Bergström, Emre M. Isin, Neal CastagnoliJr.Jr. & Claire E. Milne. (2011) Bioactivation Pathways of the Cannabinoid Receptor 1 Antagonist Rimonabant. Drug Metabolism and Disposition 39:10, pages 1823-1832.
Crossref
Crossref
Antonia F. Stepan, Daniel P. Walker, Jonathan Bauman, David A. Price, Thomas A. Baillie, Amit S. Kalgutkar & Michael D. Aleo. (2011) Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States. Chemical Research in Toxicology 24:9, pages 1345-1410.
Crossref
Crossref
Catherine D. Tsalta, Armina Madatian, Ernest M. Schubert, Fangming Xia, William M. Hardesty, Yanli Deng, Jennifer L. Seymour & Peter D. Gorycki. (2011)
Metabolism of [
14
C]GSK977779 in Rats and Its Implication with the Observed Covalent Binding
. Drug Metabolism and Disposition 39:9, pages 1620-1632.
Crossref
Crossref
Richard A. Thompson, Emre M. Isin, Yan Li, Richard Weaver, Lars Weidolf, Ian Wilson, Alf Claesson, Ken Page, Hugues Dolgos & J. Gerry Kenna. (2011) Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development. Chemico-Biological Interactions 192:1-2, pages 65-71.
Crossref
Crossref
B.K. Park, H. Laverty, A. Srivastava, D.J. Antoine, D. Naisbitt & D.P. Williams. (2011) Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chemico-Biological Interactions 192:1-2, pages 30-36.
Crossref
Crossref
Amit S. Kalgutkar. 2011. Mass Spectrometry in Drug Metabolism and Disposition. Mass Spectrometry in Drug Metabolism and Disposition
43
82
.
Vincent Mascitti, Tristan S. Maurer, Ralph P. Robinson, Jianwei Bian, Carine M. Boustany-Kari, Thomas Brandt, Benjamin M. Collman, Amit S. Kalgutkar, Michelle K. Klenotic, Michael T. Leininger, André Lowe, Robert J. Maguire, Victoria M. Masterson, Zhuang Miao, Emi Mukaiyama, Jigna D. Patel, John C. Pettersen, Cathy Préville, Brian Samas, Li She, Zhanna Sobol, Claire M. Steppan, Benjamin D. Stevens, Benjamin A. Thuma, Meera Tugnait, Dongxiang Zeng & Tong Zhu. (2011) Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors. Journal of Medicinal Chemistry 54:8, pages 2952-2960.
Crossref
Crossref
B. Kevin Park, Alan Boobis, Stephen Clarke, Chris E. P. Goldring, David Jones, J. Gerry Kenna, Craig Lambert, Hugh G. Laverty, Dean J. Naisbitt, Sidney Nelson, Deborah A. Nicoll-Griffith, R. Scott Obach, Philip Routledge, Dennis A. Smith, Donald J. Tweedie, Nico Vermeulen, Dominic P. Williams, Ian D. Wilson & Thomas A. Baillie. (2011) Managing the challenge of chemically reactive metabolites in drug development. Nature Reviews Drug Discovery 10:4, pages 292-306.
Crossref
Crossref
Joel M. Harris, Bernard R. Neustadt, Hongtao Zhang, Jean Lachowicz, Mary Cohen-Williams, Geoff Varty, Jinsong Hao & Andrew W. Stamford. (2011) Potent and selective adenosine A2A receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones. Bioorganic & Medicinal Chemistry Letters 21:8, pages 2497-2501.
Crossref
Crossref
Vincent Mascitti, Benjamin D. Stevens, Chulho Choi, Kim F. McClure, Cristiano R.W. Guimarães, Kathleen A. Farley, Michael J. Munchhof, Ralph P. Robinson, Kentaro Futatsugi, Sophie Y. Lavergne, Bruce A. Lefker, Peter Cornelius, Paul D. Bonin, Amit S. Kalgutkar, Raman Sharma & Yue Chen. (2011) Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor. Bioorganic & Medicinal Chemistry Letters 21:5, pages 1306-1309.
Crossref
Crossref
Graham F. Smith. 2011. Progress in Medicinal Chemistry Volume 50. Progress in Medicinal Chemistry Volume 50
1
47
.
Jean-François Lévesque, Stephen H. Day & Allen N. Jones. 2011. Drug Safety Evaluation. Drug Safety Evaluation
283
301
.
Siamak Cyrus Khojasteh, Harvey Wong & Cornelis E.C.A. HopSiamak Cyrus Khojasteh, Harvey Wong & Cornelis E. C. A. Hop. 2011. Drug Metabolism and Pharmacokinetics Quick Guide. Drug Metabolism and Pharmacokinetics Quick Guide
97
125
.
Yohannes Teffera, Deborah Choquette, Jingzhou Liu, Adria E. Colletti, L. Steven Hollis, Min-Hwa Jasmine Lin & Zhiyang Zhao. (2010) Bioactivation of Isothiazoles: Minimizing the Risk of Potential Toxicity in Drug Discovery. Chemical Research in Toxicology 23:11, pages 1743-1752.
Crossref
Crossref
Mark P. Grillo. 2010. Biotransformation and Metabolite Elucidation of Xenobiotics. Biotransformation and Metabolite Elucidation of Xenobiotics
245
294
.
Jian Yu, Dean G. Brown & Doug Burdette. (2010) In Vitro Metabolism Studies of Nomifensine Monooxygenation Pathways: Metabolite Identification, Reaction Phenotyping, and Bioactivation Mechanism. Drug Metabolism and Disposition 38:10, pages 1767-1778.
Crossref
Crossref
Sophie L. Regan, James L. Maggs, Thomas G. Hammond, Craig Lambert, Dominic P. Williams & B. Kevin Park. (2010) Acyl glucuronides: the good, the bad and the ugly. Biopharmaceutics & Drug Disposition 31:7, pages 367-395.
Crossref
Crossref
Amit S. Kalgutkar. 2010. Predictive Toxicology in Drug Safety. Predictive Toxicology in Drug Safety
102
123
.
Donald J. AbrahamJulian Blagg. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
301
334
.
Kevin J. Hodgetts, Charles A. Blum, Timothy Caldwell, Rajagopal Bakthavatchalam, Xiaozhang Zheng, Scott Capitosti, James E. Krause, Daniel Cortright, Marci Crandall, Beth Ann Murphy, Susan Boyce, A. Brian Jones & Bertrand L. Chenard. (2010) Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. Bioorganic & Medicinal Chemistry Letters 20:15, pages 4359-4363.
Crossref
Crossref
David S. Carter, Hai-Ying Cai, Eun Kyung Lee, Pravin S. Iyer, Matthew C. Lucas, Ralf Roetz, Ryan C. Schoenfeld & Robert J. Weikert. (2010) 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression. Bioorganic & Medicinal Chemistry Letters 20:13, pages 3941-3945.
Crossref
Crossref
Travis T. Wager, Xinjun Hou, Patrick R. Verhoest & Anabella Villalobos. (2010) Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties. ACS Chemical Neuroscience 1:6, pages 435-449.
Crossref
Crossref
Raju Subramanian, Matthew R. Lee, John G. Allen, Matthew P. Bourbeau, Christopher Fotsch, Fang-Tsao Hong, Seifu Tadesse, Guomin Yao, Chester C. Yuan, Sekhar Surapaneni, Gary L. Skiles, Xianghong Wang, G. Erich Wohlhieter, Qingping Zeng, Yihong Zhou, Xiaochun Zhu & Chun Li. (2010) Cytochrome P450-Mediated Epoxidation of 2-Aminothiazole-Based AKT Inhibitors: Identification of Novel GSH Adducts and Reduction of Metabolic Activation through Structural Changes Guided by in Silico and in Vitro Screening. Chemical Research in Toxicology 23:3, pages 653-663.
Crossref
Crossref
Mark P. Grillo. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
42
.
Carl D. Davis & Umesh M. Hanumegowda. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
68
.
Dan Rock & Larry C. Wienkers. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
56
.
Mhairi L. Greer, Jane Barber, Julie Eakins & J. Gerry Kenna. (2010) Cell based approaches for evaluation of drug-induced liver injury. Toxicology 268:3, pages 125-131.
Crossref
Crossref
John Kelly. 2010. Principles of CNS Drug Development. Principles of CNS Drug Development
211
244
.
Jian Yu, Donald E. Mathisen, Doug Burdette, Dean G. Brown, Christopher Becker & David Aharony. (2010) Identification of Multiple Glutathione Conjugates of 8-Amino- 2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline maleate (Nomifensine) in Liver Microsomes and Hepatocyte Preparations: Evidence of the Bioactivation of Nomifensine. Drug Metabolism and Disposition 38:1, pages 46-60.
Crossref
Crossref
Kenny De Wolf, Lieve Balcaen, Elke Van De Walle, Filip Cuyckens & Frank Vanhaecke. (2010) A comparison between HPLC-dynamic reaction cell-ICP-MS and HPLC-sector field-ICP-MS for the detection of glutathione-trapped reactive drug metabolites using clozapine as a model compound. Journal of Analytical Atomic Spectrometry 25:3, pages 419.
Crossref
Crossref
A. Srivastava, J. L. Maggs, D. J. Antoine, D. P. Williams, D. A. Smith & B. K. Park. 2010. Adverse Drug Reactions. Adverse Drug Reactions
165
194
.
Sanjeev Kumar, Kaushik Mitra, Kelem Kassahun & Thomas A. Baillie. 2010. Adverse Drug Reactions. Adverse Drug Reactions
511
544
.
María José Gómez-Lechón, José V. Castell & María Teresa Donato. 2010. Hepatocytes. Hepatocytes
389
415
.
Tonika Bohnert & Liang‐Shang Gan. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
91
176
.
Toru Usui, Masashi Mise, Takanori Hashizume, Masashi Yabuki & Setsuko Komuro. (2009) Evaluation of the Potential for Drug-Induced Liver Injury Based on in Vitro Covalent Binding to Human Liver Proteins. Drug Metabolism and Disposition 37:12, pages 2383-2392.
Crossref
Crossref
Yan Liang, Li Liu, Shousi Lu, Lin Xie, An Kang, Tong Xie, Yuan Xie, Longsheng Sheng, Xiaodong Liu & Guang-ji Wang. (2009) Application of a hybrid ion trap/time-of-flight mass spectrometer in metabolite characterization studies: Structural identification of the metabolism profile of antofloxacin in rats rapidly using MSn information and accurate mass measurements. Journal of Pharmaceutical and Biomedical Analysis 50:5, pages 1022-1025.
Crossref
Crossref
César Ramírez-Molina & Lucy Burton. (2009)
Screening strategy for the rapid detection of
in vitro
generated glutathione conjugates using high-performance liquid chromatography and low-resolution mass spectrometry in combination with LightSight® software for data processing
. Rapid Communications in Mass Spectrometry 23:22, pages 3501-3512.
Crossref
Crossref
Amit S. Kalgutkar & Mary T. Didiuk. (2009) Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity?. Chemistry & Biodiversity 6:11, pages 2115-2137.
Crossref
Crossref
Jinghai J. Xu, Amit S. Kalgutkar, Yvonne Will, James Dykens, Elizabeth Tengstrand & Frank Hsieh. 2009. Hit and Lead Profiling. Hit and Lead Profiling
345
385
.
Jonathon N. Bauman, Joan M. Kelly, Sakambari Tripathy, Sabrina X. Zhao, Wing W. Lam, Amit S. Kalgutkar & R. Scott Obach. (2009) Can In Vitro Metabolism-Dependent Covalent Binding Data Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis Using Human Hepatocytes and Liver S-9 Fraction. Chemical Research in Toxicology 22:2, pages 332-340.
Crossref
Crossref
Mark P. Grillo. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
655
696
.
Carl D. Davis & Umesh M. Hanumegowda. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
559
628
.
Dan Rock & Larry C. Wienkers. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
479
534
.
Guodong Chen, Ibrahim Daaro, Birendra N. Pramanik & John J. Piwinski. (2009)
Structural characterization of
in vitro
rat liver microsomal metabolites of antihistamine desloratadine using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange HR-LC/MS
. Journal of Mass Spectrometry 44:2, pages 203-213.
Crossref
Crossref
Thomas N. Thompson. 2009. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry Volume 44
459
474
.
Jacques Descotes. 2009. Information Resources in Toxicology. Information Resources in Toxicology
313
319
.
Deepak Dalvie, Ping Kang, Michael Zientek, Cathie Xiang, Sue Zhou & R. Scott Obach. (2008) Effect of Intestinal Glucuronidation in Limiting Hepatic Exposure and Bioactivation of Raloxifene in Humans and Rats. Chemical Research in Toxicology 21:12, pages 2260-2271.
Crossref
Crossref
Xiaohu Zhang, John E. Tellew, Zhiyong Luo, Manisha Moorjani, Emily Lin, Marion C. Lanier, Yongsheng Chen, John P. Williams, John Saunders, Sandra M. Lechner, Stacy Markison, Tanya Joswig, Robert Petroski, Jaime Piercey, William Kargo, Siobhan Malany, Mark Santos, Raymond S. Gross, Jenny Wen, Kayvon Jalali, Zhihong O’Brien, Carol E. Stotz, María I. Crespo, José-Luis Díaz & Deborah H. Slee. (2008)
Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A
2A
Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease
. Journal of Medicinal Chemistry 51:22, pages 7099-7110.
Crossref
Crossref
Jason D. Hughes, Julian Blagg, David A. Price, Simon Bailey, Gary A. DeCrescenzo, Rajesh V. Devraj, Edmund Ellsworth, Yvette M. Fobian, Michael E. Gibbs, Richard W. Gilles, Nigel Greene, Enoch Huang, Teresa Krieger-Burke, Jens Loesel, Travis Wager, Larry Whiteley & Yao Zhang. (2008) Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorganic & Medicinal Chemistry Letters 18:17, pages 4872-4875.
Crossref
Crossref
Jonathan N. Bauman, Kosea S. Frederick, Aarti Sawant, Robert L. Walsky, Loretta M. Cox, Ronald S. Obach & Amit S. Kalgutkar. (2008) Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug. Drug Metabolism and Disposition 36:6, pages 1016-1029.
Crossref
Crossref
Heng-Keang Lim, Jie Chen, Kevin Cook, Carlo Sensenhauser, Jose Silva & David C. Evans. (2008) A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry. Rapid Communications in Mass Spectrometry 22:8, pages 1295-1311.
Crossref
Crossref
Deborah H. Slee, Yongsheng Chen, Xiaohu Zhang, Manisha Moorjani, Marion C. Lanier, Emily Lin, Jaimie K. Rueter, John P. Williams, Sandra M. Lechner, Stacy Markison, Siobhan Malany, Mark Santos, Raymond S. Gross, Kayvon Jalali, Yang Sai, Zhiyang Zuo, Chun Yang, Julio C. Castro-Palomino, María I. Crespo, Maria Prat, Silvia Gual, José-Luis Díaz & John Saunders. (2008)
2-Amino-
N
-pyrimidin-4-ylacetamides as A
2A
Receptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents
. Journal of Medicinal Chemistry 51:6, pages 1719-1729.
Crossref
Crossref
Xiaohu Zhang, Jaimie K. Rueter, Yongsheng Chen, Manisha Moorjani, Marion C. Lanier, Emily Lin, Raymond S. Gross, John E. Tellew, John P. Williams, Sandra M. Lechner, Stacy Markison, Tanya Joswig, Siobhan Malany, Mark Santos, Julio C. Castro-Palomino, Marı´a I. Crespo, Maria Prat, Silvia Gual, José-Luis Díaz, John Saunders & Deborah H. Slee. (2008) Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters 18:6, pages 1778-1783.
Crossref
Crossref
Thomas A. Baillie. (2007) Metabolism and Toxicity of Drugs. Two Decades of Progress in Industrial Drug Metabolism. Chemical Research in Toxicology 21:1, pages 129-137.
Crossref
Crossref
F. Peter Guengerich. (2007) Cytochrome P450 and Chemical Toxicology. Chemical Research in Toxicology 21:1, pages 70-83.
Crossref
Crossref
Peter Imming. 2008. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry
63
72
.
Amit S. Kalgutkar. 2008. Advances in Bioactivation Research. Advances in Bioactivation Research
1
29
.
Sabrina X. Zhao, Deepak K. Dalvie, Joan M. Kelly, John R. Soglia, Kosea S. Frederick, Evan B. Smith, R. Scott Obach & Amit S. Kalgutkar. (2007)
NADPH-Dependent Covalent Binding of [
3
H]Paroxetine to Human Liver Microsomes and S-9 Fractions: Identification of an Electrophilic Quinone Metabolite of Paroxetine
. Chemical Research in Toxicology 20:11, pages 1649-1657.
Crossref
Crossref
F. Peter Guengerich. (2007) Mechanisms of cytochrome P450 substrate oxidation: MiniReview. Journal of Biochemical and Molecular Toxicology 21:4, pages 163-168.
Crossref
Crossref
F Guengerich. 2007. Drug-Induced Liver Disease, Second Edition. Drug-Induced Liver Disease, Second Edition
13
31
.
Jean-François Lévesque, Stephen H. Day, Nathalie Chauret, Carmai Seto, Laird Trimble, Kevin P. Bateman, José M. Silva, Carl Berthelette, Nicolas Lachance, Michael Boyd, Lianhai Li, Claudio F. Sturino, Zhaoyin Wang, Robert Zamboni, Robert N. Young & Deborah A. Nicoll-Griffith. (2007) Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: Impacts of glutathione trapping and glucuronide conjugation on covalent binding. Bioorganic & Medicinal Chemistry Letters 17:11, pages 3038-3043.
Crossref
Crossref
William Loging, Lee Harland & Bryn Williams-Jones. (2007) High-throughput electronic biology: mining information for drug discovery. Nature Reviews Drug Discovery 6:3, pages 220-230.
Crossref
Crossref
F. Peter Guengerich & James S. MacDonald. (2007) Applying Mechanisms of Chemical Toxicity to Predict Drug Safety. Chemical Research in Toxicology 20:3, pages 344-369.
Crossref
Crossref
Emre M. Isin & F. Peter Guengerich. (2007) Complex reactions catalyzed by cytochrome P450 enzymes. Biochimica et Biophysica Acta (BBA) - General Subjects 1770:3, pages 314-329.
Crossref
Crossref
Yuan Chen, Mario Monshouwer & William L. Fitch. (2006) Analytical Tools and Approaches for Metabolite Identification in Early Drug Discovery. Pharmaceutical Research 24:2, pages 248-257.
Crossref
Crossref
Shuguang Ma & Raju Subramanian. (2006) Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry. Journal of Mass Spectrometry 41:9, pages 1121-1139.
Crossref
Crossref
Thomas A. Baillie. (2006) Future of ToxicologyMetabolic Activation and Drug Design: Challenges and Opportunities in Chemical Toxicology. Chemical Research in Toxicology 19:7, pages 889-893.
Crossref
Crossref
Graham Lappin. 2006. Radiotracers in Drug Development. Radiotracers in Drug Development
41
118
.
F. Peter Guengerich. (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. The AAPS Journal 8:1, pages E101-E111.
Crossref
Crossref
John R. Soglia, Leonard G. Contillo, Amit S. Kalgutkar, Sabrina Zhao, Cornelis E. C. A. Hop, James G. Boyd & Mark J. Cole. (2006) A Semiquantitative Method for the Determination of Reactive Metabolite Conjugate Levels in Vitro Utilizing Liquid Chromatography−Tandem Mass Spectrometry and Novel Quaternary Ammonium Glutathione Analogues. Chemical Research in Toxicology 19:3, pages 480-490.
Crossref
Crossref
Scott M. Peterman, Nicholas Duczak, Amit S. Kalgutkar, Mary E. Lame & John R. Soglia. (2006) Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: Examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements. Journal of the American Society for Mass Spectrometry 17:3, pages 363-375.
Crossref
Crossref
Julian Blagg. 2006. Annual Reports in Medicinal Chemistry Volume 41. Annual Reports in Medicinal Chemistry Volume 41
353
368
.